Available online at: (Accessed September 15, 3023)
From nutrients to smart satiety in product design If biomimetics work, CPG formulation moves beyond adding bulk or protein toward purpose-built satiety signals
PeptideStack is an independent research resource
Retatrutide: The Next Generation of Diabetes and Weight Loss Medication Just when you thought GLP-1 medications couldn't get more impressive, here comes retatrutide
Authors: Karen G Farrar University of Southern California , Los Angeles, CA, Duy Do Truveta, Inc , Bellevue, WA, Nina B Masters Truveta, Inc , Bellevue, WA, Brianna M Cartwright Truveta, Inc , Bellevue, WA After CVS Caremark made anti-obesity semaglutide the preferred formulary option in July 2025, switching from anti-obesity tirzepatide surged from 0.6% to 9.7%, representing more than a 16-fold rise